Kirk Chester joins medac Pharma as lead for newest oncology product

medac Pharma has appointed Kirk Chester as National Account Manager for the organisation’s newest hepatic oncology product, CHEMOSAT®.

Kirk brings with him 18 years’ experience in the pharmaceutical industry and his extensive knowledge of both secondary and primary care will be key to medac’s continued growth plans for its portfolio of oncology products.  Having previously worked for Novartis, Teva and GSK, Kirk has worked within many healthcare sectors including oncology, ophthalmology, men’s health and urology and is delighted to join medac Pharma to promote a product that can help people with inoperable liver cancer.

Managing Director of Stirling based medac Pharma, Alastair McMurray, comments: “We are delighted that Kirk has joined the company and his appointment will be pivotal in driving the company’s growth as we strive to be a global player in the field of oncology.”

  • European Association of Urology (EAU)

    20 – 24 March 2020
    RAI, Amsterdam
    Urology

  • Anthony Nolan – Symposium – Innovative Cell Therapies

    20 March 2020
    Royal College of Physicians, London
    Haematology

  • EMBT – European Bone Marrow Transplantation

    22 – 25 March 2020
    IFEMA, Madrid
    Haematology

  • BSR – British Society of Rheumatology

    20 – 22 April 2020
    SEC, Glasgow
    Rheumatology

  • Melanoma Focus

    15 May 2020
    Leonardo Royal Southampton Grand Harbour Hotel, Southampton
    Oncology

  • SOPPG – Scottish Oncology Pharmacy Practice Group

    06 June 2020
    Doubletree Hilton, Dunblane
    Oncology

  • EULAR – European League Against Rheumatism

    03 – 06 June 2020
    MESSE, Frankfurt
    Rheumatology

  • Oncology Forum

    11 – 12 June 2020
    ICC, Birmingham
    Oncology

  • BAUS – British Association of Urology Surgeons

    15 – 17 June 2020
    BAUS, Birmingham
    Urology

  • BAD – British Association of Dermatology

    07 – 09 June 2020
    ACC, Liverpool
    Dermatology

  • NMIBC Workshops: Intravesical therapies – An update on theory and practice

    Register your interest.